Sandra P. Susanibar-Adaniya, MD, MS

Shan X, Susanibar-Adaniya SP. When timing matters most: Early relapse outweighs baseline risk in myeloma. , Cancer Medicine, 15(5): 2026,e71900.

Susanibar-Adaniya S, Derman BA, Cohen AD, Vogl DT, Richard S, Rossi A, Frigualt MJ, Yee AJ, Dhakal B, Bar N. Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: Insights from a multicenter case series , Blood Cancer Journal , 28(16): 2026,64

Heta Patel, Harper Hubbeling, Kyle L. Yu, Maribel Carpenter, Michael J. LaRiviere, John P. Plastaras, Adam D. Cohen, Shivani Kapur, Dan T Vogl, Adam J Waxman, Edward A Stadtmauer, Alfred L Garfall, Sandra Patricia Susanibar-AdaniyaCorresponding Author Outcomes of Radiation Integrated with T-cell-engaging Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma , Blood advances, 10(4): 2026,1395-1399.

Ho M, Paruzzo L, Noll JH, Stella F, Devi P, Ndeupen S, Day YA, Chen GM, Cohen IJ, Ramirez-Fernandez A, Waxman A, Kapur S, Chen F, Xu R, Huff A, Jarocha D, Patel V, Bochi-Layec AC, Ramasubramanian R, Liu S, Bouvier R, de Souza VB, Patel H, Li Z, Carturan A, Michener P, Hopkins CR, Koucky O, Minehart J, Dimitri A, Nabar NR, Hasanali ZS, Ciccarelli BT, Hung P, Williams E, Bartoszek R, Lavorando M, Mohan S, Gonzalez VE, Porazzi P, Bhoj VG, Apostolidis SA, Vogl DT, Porter DL, Scholler J, Diorio C, Roche AM, Everett JK, Bushman FD, Nathanson KL, Stadtmauer EA, Susanibar-Adaniya SP, Garfall AL, Ruella M, Cohen AD, Fraietta JA. CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy. , Nature Medicine, 32(2): 2026,702-716

Chen A, Smith KD, Wu RI, Ma K, Susanibar-Adaniya SP When sarcoidosis looks like myeloma: a diagnostic pitfall , Ann Intern Med Clin Cases, 5(1): 2026,10.7326/aimcc.2025.1000

Kyle L. Yu, Matthew Ho, Luca Paruzzo, Federico Stella, Heta Patel, Zainul S. Hasanali, Shivani Kapur, Adam J. Waxman, Dan T. Vogl, Edward A. Stadtmauer, Joseph A. Fraietta, Marco Ruella, Adam D. Cohen, Alfred L. Garfall & Sandra Susanibar-Adaniya Outcomes of relapse after teclistamab therapy in multiple myeloma , Blood Cancer Journal, 15(1): 2025,193

Beatrice M. Razzo; Shonali Midha; Andrew J. Portuguese, Ariel F. Grajales-Cruz; Andre De Menezes Silva Corraes, Patrick Costello; Yuxin Liu; Adam S. Sperling; Omar Nadeem, Danai Dima; Rahul Banerjee; Andrew J.Rowan; Aimaz Afrough; Larry D. Anderson; Alex Lieberman-Cribbin; Gurbakhash Kaur; Anmol Goyal; Shebli Atrash; Christopher J. Ferreri; Peter M. Voorhees; Oren Pasvolsky; Hans C. Lee; Krina K. Patel; Kelley L. Julian; Peter A. Forsberg; Megan M. Herr; Saurabh Chhabra; Ricardo D. Parrondo; Yi Lin; Anna Chen; Sandra P. Susanibar-Adaniya; Jack Khouri; Shahzad Raza; Faiz Anwer; Mariola Vazquez-Martinez; Omar Castaneda Puglianini ; Douglas W. Sborov; James A. Davis, Adriana Rossi; Leyla Shune; Jenny Bhurtel; Wei-Ting Hwang; Doris K. Hansen; Surbhi Sidana; Alfred L. Garfall;Shambavi Richard Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium , Blood Cancer Discovery, 6(6): 2025,561-571

Xinhe Shan, Rowan Kuiper, Chuling Ding, Pashna N Munshi, Edward A Stadtmauer, Sandra P Susanibar-Adaniya Age-related disparities in treatment and outcomes for newly diagnosed multiple myeloma: a population-based study , Haematologica , 110(11): 2025,2839-2843.

Dima D, Afrough A, Goel U, Grajales-Cruz A, Khouri J, Julian K, Pasvolsky O, Banerjee R, Razzo B, Ferreri CJ, Vazquez Martinez MA, Davis JA, Sannareddy A, Castaneda Puglianini O, Raza S, Portuguese AJ, Gaballa MR, Rana M, Lieberman-Cribbin A, DeJarnette S, Gonzalez R, Chen A, Herr MM, Mikkilineni L, Hosoya H, Ouchveridze E, Kaur G, Rossi AC, Shune L, Anwer F, Lin Y, Richard S, Sborov DW, Baz RC, Garfall A, Lee HC, Anderson LD Jr, Cowan AJ, Patel KK, Voorhees PM, Sidana S, Hansen DK, Atrash S, Susanibar-Adaniya SP. Teclistamab for Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma and Renal Impairment , Blood Advances, 9(14): 2025,3408-3417

Luca Paruzzo, Khashayar Eshaghi, Guido Ghilardi, Abigail Doucette, Matthew Ho, Alberto Carturan, Dan T. Vogl, Adam J. Waxman, Shivani Kapur, Eugenio Fardella, Martina Pucillo, Antonio Imparato, Federico Stella, Puneeth Guruprasad, Vitor B. De Souza, Luke Maillie, Sofia Kaparis, Riemke Bouvier Bs, Adam D. Cohen, Jalpa A. Doshi, David L. Porter, Alfred L. Garfall, , Edward A. Stadtmauer, Carmen E. Guerra, Sandra P. Susanibar Adaniya, Marco Ruella Access and Outcomes of Racial and Ethnic Minority Populations Receiving Commercial Anti-BCMA CART for Myeloma , Blood Immunology & Cellular Therapy/American Society of Hematology Annual Meeting, Orlando, FL.: 2025